Evo shortage status
1 active shortage notice across 1 country.
Last updated 8 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Evo
- Class
- Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Where Evo is in shortage
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | high | 1 | 10 Sept 2026 | — | FDA-FE |
Why Evo is in shortage
- manufacturing problems — e.g. “CGMP Deviations.” (United States)
Frequently asked questions
Is Evo currently in shortage?
Yes. As of the latest regulator updates, Evo has 1 active shortage notice across 1 country (United States). Status is refreshed daily from official regulatory sources.
Why is Evo in shortage?
Regulators attribute the current Evo shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Evo shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Evo status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.